Phase II Combination Steroid and Anti-VEGF for Persistent DME

NCT01945866 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: intravitreal ranibizumab 0.3 mg
DRUG: dexamethasone intravitreal implant
PROCEDURE: Sham injection

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]
[object Object]